PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database

Study backs RSV vaccine safety during pregnancy

Farmacéuticos salvavidas: bloqueo cautelar y diálogo entre especialistas, claves para la salud del paciente

La AEMPS notifica 42.333 sospechas de reacciones adversas a medicamentos en 2023

La AEMPS publica el Informe Anual del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano

Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization

Revisión narrativa: las incompatibilidades farmacológicas ¿son prevenibles? Análisis de enfermería

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections

Assessing the knowledge, attitude, and practice of hospital-based pharmacists in reporting adverse drug reactions in Lagos, Nigeria

The ethics of artificial intelligence systems in healthcare and medicine: from a local to a global perspective, and back

A national survey on assessment of knowledge, perceptions, practice, and barriers among hospital pharmacists towards medication reconciliation in United Arab Emirates

Two spurious drugs falsely labeled as manufactured by Abbot India were seized by Telangana DC officials

Probiotics and Antibiotic-Induced Microbial Aberrations in Children. A Secondary Analysis of a Randomized Clinical Trial

Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study

Evaluating the Robustness of Adverse Drug Event Classification Models Using Templates

A four-year assessment of the characteristics of Rwandan FDA drug recalls

Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis

Eight Common Antidepressants Ranked by Weight Gain Potential

Weight Gain From Discontinuing GLP-1s a Concern in Pregnancy

Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study

Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study protocol: a prospective observational cohort study of reproductive-aged women living with HIV

Cofepris alerta sobre falsificación y venta ilegal de medicamento para hipotiroidismo

Improving Outpatient Medication Reconciliation And Reducing Adverse Drug E erse Drug Events: De ents: Development Of A New Pr elopment Of A New Process

PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

DrugWatch: A Comprehensive Multi-Source Data Visualisation Platform for Drug Safety Information

Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 2: Major Congenital Malformations With Antiepileptic Drug Monotherapy

WHO Warns Against Counterfeit Ozempic in Europe and the United States

Sildenafil-induced drug reaction with eosinophilia and systemic symptoms

Study links weight-loss drug to rare eye condition

Gobierno observa autógrafa de Ley sobre acceso a medicamentos y dispositivos médicos en base a informe del Ministerio de Salud

Age‐related off‐label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan

A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data

Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season

In-Vitro Safety Assessment of Meropenem on Human Retinal Pigment Epithelium (RPE)

Environmental Monitoring for Sterile Hazardous Drug Compounding

Deciphering Factors Contributing to Cost-Effective Medicine Using Machine Learning

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

Europe Acts to Address GLP-1 Drug Shortages